Enpp-1-IN-7

Enpp-1-IN-7

• UNSPSC Description: Enpp-1-IN-7 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-7 has the potential for the research of cancer and infectious diseases (extracted from patent WO2021203772A1, compound 51)[1].
• Target Antigen: Phosphodiesterase (PDE)
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Applications: COVID-19-immunoregulation
• Field of Research: Cancer; Infection
• Assay Protocol: https://www.medchemexpress.com/enpp-1-in-7.html
• Solubility: 10 mM in DMSO
• Smiles: NS(NC1=CC=C(CNC2=NC3=NN=CN3C4=CC(OC)=C(OC)C=C24)C=C1)(=O)=O
• Molecular Weight: 429.45
• References & Citations: [1]Bang Fu, et al. Ectonucleotide pyrophosphatase-phosphodiesterase 1 inhibitors,compositions and uses thereof. Patent WO2021203772A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported